ALDH1A1 and breast neoplasm: revealed that ALDH1A1 results MDSCs infiltration in 4T1 breast tumor mouse models, and the administration of DSF robustly enhances the therapeutic efficiency of PD‐L1 monoclonal antibody in vivo.